About us

Jilin Zhongke Bio-engineering Co., Ltd. (JZB) founded in May 2007. JZB registered address is Changchun City, Jilin Province of P. R. China. Registered capital is 100 million RMB. JZB mainly engaged in Stem cell collection, stem cell preparation of production, clinical application of stem cell transplantation and other services.

JZB now has professional and technical R & D personnel 33 people, 21 of them access to biological engineering and biochemistry Master's, Ph.D. JZB in the application of stem cells to treat cancer, diabetes, nerve damage, autoimmune diseases has made a definite effect, so far, the accumulated cases of clinical research are more than 3000 times, the implementation of stem cell transplantation reaches up to more than 10,000 times of injections.

For cancer, diabetes, severe liver disease, nervous system damage, cerebral palsy, nephropathy, autoimmune diseases, and other sub indications of health and beauty have a significant effect. Company currently has the stem cell frozen storage capacity could meet the demands goes up to 10,000 per year. On stem cell technology platform, technology system, the equipments necessary rise up to the level A (China).

JZB from stem cell attracts domestic and foreign patients to Changchun. Like Dr. Michael Berman, US Invest Group Chairman. Dr. Berman was director of New York Presbyterian Hospital，the CEO and Vice Chairman, Beijing China-US Friendship Medical Center – Harvard Medical International Institution, accompanying with his wife Susan, who suffered from amyotrophic lateral sclerosis (ALS), Prince Faisal and Princess Hanna from Saudi Arabia(ALS), Director for healthy affairs from western region of Saudi Arabia, ministerial officials of Saudi Arabia, and other friends all over the world.